Napp Pharmaceuticals is a member of the Mundipharma network of independent associated companies.

Mundipharma is a global (ex-US) network of independent associated companies that research, develop and manufacture innovative pharmaceutical medicines and consumer healthcare products.  We are an agile and fast-paced company seeking to increase access to health care through programmes and effective partnerships.  

We are forward-looking and dedicated to bringing innovative treatments to many of the world’s most challenging conditions and diseases including:  Pain Management & Supportive Care, Consumer Health,  Anti-Infectives, Biosimilars, CNS, Diabetes, Oncology, Ophthalmology, Respiratory and transplantation immunity. 

We make a difference to patient lives by delivering value to healthcare professionals in 120+ countries across Africa,  Asia Pacific, Canada, Europe, Latin America and the Middle East.

Our guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything we do.  We encourage our people to think differently and our inclusive culture of continuous learning and collaboration make Mundipharma a great place to work.   

Pharmaceutical

Health Care

Napp Pharmaceuticals Limited

Napp Pharmaceuticals Limited's headquarters in Cambridge, United Kingdom

Neelam K.

Gary Cox

Ian Greenacre

Keith Price

Neil MacDonald

Zumurd Khan

Claire Sherwin

Lucy Hulley

Robert Mercer

Richard Crook

David Lewis

Josh Deo

Bill Shepherd

Graz Celer

Allison Hogg

Gerald Peters

Balwinder Singh

Lisa Brown

Debby Parlett

Helen Davis

Trevor Large

Adam Sharman

Philip Ball

Description